Search
Cencora Inc
CORAdd to Watchlist
271.380USD
-0.450-0.17%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
52.80BMarket Cap
20.69P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-0.17%
5 Days
-3.57%
1 Month
-1.28%
6 Months
-20.19%
Year to Date
-19.65%
1 Year
-7.59%
Key Figures
270.980Open
274.120High
1.66MVolume
20.69P/E TTM
13.95P/E Dynamic
2.300Dividend TTM
0.85%Turnover Ratio
271.830Prev. Close
269.300Low
211.45MTurnover
33.97P/E Static
15.54P/B
0.85%Div Yield TTM
3.34%ROA
377.54052wk High
0.95Volume Ratio
1.55BNet Profit
194.56MShares
13.1155EPS TTM
0.60Beta
115.58%ROE
244.82052wk Low
1.77%Amplitude
4.26%Gross Margin
52.80BMarket Cap
1.72Reward/Risk
1.40%Risk Rate
TradingKey Stock Score of Cencora Inc
Currency: USD Updated: 2026-06-22Key Insights
Cencora Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 4 out of 203 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 353.18.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Cencora Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
27°C
Very Low
Very High
Neutral
Cencora Inc Highlights
StrengthsRisks
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 321.33B.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 22.56% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 28.12%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 28.12%.
Undervalued
The company’s latest PE is 20.68, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 188.32M shares, increasing 0.50% quarter-over-quarter.
Held by Manning & Napier Group, LLC
Star Investor Manning & Napier Group, LLC holds 95.28K shares of this stock.
Analyst Rating
Based on
16
analysts
Buy
Current Rating
353.176
Target Price
+29.93%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Cencora Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Cencora Inc Info
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Ticker SymbolCOR
CompanyCencora Inc
CEOMauch (Robert P)
Websitehttps://www.cencora.com/
Related Instruments
+1.42%
-0.07%
-0.72%
-0.96%
+3.03%
+0.63%
-1.01%
-0.09%
+1.65%
+0.45%
+0.98%
-2.15%
-1.69%
+0.07%
-2.91%
-2.27%
-0.46%
-1.03%
+0.80%Popular Instruments
73.025
-0.964 (-1.30%)
297.230
-0.780 (-0.26%)
208.780
-1.910 (-0.91%)
4119.130
-71.120 (-1.70%)
732.810
-13.420 (-1.80%)
2273.370
+88.620 (+4.06%)
1213.000
+79.010 (+6.97%)
349.710
-18.320 (-4.98%)
63414.700
-989.100 (-1.54%)
404.920
+4.430 (+1.11%)
FAQs
What is the current price of Cencora Inc (COR)?
The current price of Cencora Inc (COR) is 271.38.
What is the symbol of Cencora Inc?
The ticker symbol of Cencora Inc is COR.
What is the 52-week high of Cencora Inc?
The 52-week high of Cencora Inc is 377.54.
What is the 52-week low of Cencora Inc?
The 52-week low of Cencora Inc is 244.82.
What is the market capitalization of Cencora Inc?
The market capitalization of Cencora Inc is 52.80B.
Is Cencora Inc (COR) currently rated as Buy, Hold, or Sell?
According to analysts, Cencora Inc (COR) has an overall rating of Buy, with a price target of 353.18.
What is the Earnings Per Share (EPS TTM) of Cencora Inc (COR)?
The Earnings Per Share (EPS TTM) of Cencora Inc (COR) is 8.02.
